Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

Clinical trial NCT06715891 · RECRUITING

Trial details

NCT number: NCT06715891
Sponsor: Materia Medica Holding
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Viral Infection

Start date: 2024-11-11
Primary completion: 2027-12-31
Enrollment: 374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.